Skip to main content

MYLAN CF 135 MYLAN CF 135 Pill - blue & yellow capsule/oblong

Pill with imprint MYLAN CF 135 MYLAN CF 135 is Blue & Yellow, Capsule/Oblong and has been identified as Fenofibric Acid Delayed-Release 135 mg. It is supplied by Mylan Pharmaceuticals Inc.

Fenofibric acid is used in the treatment of Hypertriglyceridemia; High Cholesterol and belongs to the drug class fibric acid derivatives. Risk cannot be ruled out during pregnancy. Fenofibric acid 135 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for MYLAN CF 135 MYLAN CF 135

Fenofibric acid delayed-release 135 mg MYLAN CF 135 MYLAN CF 135
Fenofibric acid delayed-release 135 mg MYLAN CF 135 MYLAN CF 135
Fenofibric acid delayed-release 135 mg MYLAN CF 135 MYLAN CF 135

Fenofibric Acid Delayed-Release

Imprint
MYLAN CF 135 MYLAN CF 135
Strength
135 mg
Color
Blue & Yellow
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
Fibric acid derivatives
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
Inactive Ingredients
silicon dioxide, gelatin, hydroxypropyl cellulose, hypromelloses, methacrylic acid - ethyl acrylate copolymer (1:1) type a, polysorbate 80, povidone, sodium lauryl sulfate, sodium stearyl fumarate, magnesium silicate, titanium dioxide, triethyl citrate, ferric oxide yellow, FD&C Blue No. 2, ammonia, ferrosoferric oxide, propylene glycol, shellac

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00378-2590 (Discontinued) Mylan Pharmaceuticals Inc.
51079-0196 (Discontinued) UDL Laboratories Inc.

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.